Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 ...

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in patients ...

In this powerful reflection, Debra Lee shares her journey from “the good girl” to a trailblazing CEO, revealing the ...

Recently, the first-ever OpenHarmony Technical Forum in Europe successfully concluded in Rotterdam, the Netherlands. Centered on the theme of “OpenHarmony Technology Innovation and Ecosystem Practice, ...

Skin lesions may hold the key to diagnosing dengue, Zika, chikungunya, and Oropouche fever. Learn how dermatologists can spot ...

Artificial intelligence startup Cohere Inc. today launched Embed 4, its latest AI model designed to provide embeddings for ...

Abnormal Security, the leader in AI-native human behavior security, today announced it has rebranded as Abnormal AI, a move that reflects its evolution into a broader AI-native security platform ...

But that doesn't mean it doesn't attract the fine folks working on open-source software. Like Windows and Linux, the Mac has ...

Scottish farms have reported cases of congenital malformations in livestock linked to the Schmallenberg virus (SBV).

This study provides valuable insights into how auditory stimuli influence the temporal dynamics of visual perception by modulating brain rhythms (oscillations) in the alpha band. The authors present ...

Accenture's strong global presence and focus on technology and outsourcing have positioned it for sustainable growth. Read ...

Carrier Global's strategic focus on HVAC, boosted by Viessmann acquisition, strengthens its position in decarbonization, ...